Riskpilot← Back to searchSign inGet full accessWasa Medicals Trading AB
ABActiveOrg 5569861247Schélevägen 1Wholesale of other food · NACE 4638Est. 20142 employees
Revenue 2025
SEK 4,9M
+8% vs 2024
EBITDA margin
8.3%
-10% vs 2024
Equity ratio
64.1%
Financial strength
Net profit 2025
SEK 48K
+5305% vs 2024
| Revenue | SEK 4,9M | +8% |
| EBITDA | SEK 405K | -10% |
| Net profit | SEK 48K | +5305% |
| Total assets | SEK 3,7M | -17% |
| Equity | SEK 2,4M | +2% |
| Employees | 2 | — |
Legal name
Wasa Medicals Trading AB
Org number
5569861247
Legal form
Aktiebolag
NACE code
4638 · Wholesale of other food
Founded
14 oktober 2014
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolagets verksamhet ska vara att bedriva försäljning av kosttillskott, farmaceutiska, functional food, läkemedel och bedriva medicinsk konsultationsverksamhet.
Address
Schélevägen 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 755 | 6 790 | 5 915 | 4 504 | 4 885 |
| Staff expenses | — | −1 253 | −1 221 | −1 554 | −1 411 |
| EBITDA | 1 527 | 2 223 | 1 795 | 451 | 405 |
| Depreciation & amort. | −3 | — | — | — | — |
| EBIT | 1 524 | 2 223 | 1 795 | 451 | 405 |
| Net financials | −1 | −2 | 0 | 0 | 5 |
| Profit before tax | 723 | 670 | 445 | 1 | 60 |
| Tax | −155 | −138 | −92 | −0 | −11 |
| Net profit | 568 | 532 | 353 | 1 | 48 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 954 | 3 956 | 4 798 | 4 452 | 3 708 |
| Equity | 1 440 | 1 973 | 2 326 | 2 327 | 2 375 |
| Long-term debt | 0 | 0 | 21 | 8 | 59 |
| Short-term debt | 2 513 | 1 983 | 2 452 | 2 118 | 1 274 |
| Total debt | 2 513 | 1 983 | 2 473 | 2 126 | 1 333 |
EBITDA margin
8.3%
This company
15.8%
Market median
-47% vs market
20212025
Equity ratio
64.1%
This company
38.2%
Market median
+68% vs market
20212025
Return on equity
2.0%
This company
18.4%
Market median
-89% vs market
20212025
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
20212025
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20212025
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM | Audit | 2022 |
| Former (1) | ||
ML | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Wasa Medicals AB
Wasa Medicals Trading AB Board members of Wasa Medicals Trading AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats-Åke Lennart Andersson | Audit | 0 companies |
| Anna Michaela Bruzell | Audit | 0 companies |
| Per Lennart Cedgård | Board of Directors | 0 companies |
| Katarzyna Magdalena Cedgård | Deputy Board Member | 0 companies |